Atlas Trials

Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)

Clinical trial NCT05778097 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05778097
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerBiochemical RecurrenceHigh Risk
Start date
2023-04-01
Primary completion
2026-08-31
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.